Table 1.
General detailed attributes of the included studies
| Name of the study | Type of study | Total number of patients | M/F ratio | Number of malignant and metastatic tumor | Site of the defect | Outcome studied | Disclosure | Level of evidence |
|---|---|---|---|---|---|---|---|---|
| Wang et al [12] | Retrospective | 25 | 10/15 | 20 | Proximal humerus tumor | Functional outcome (MSTS), complications | Not reported | IV |
| Michiel van de sande [13] | Retrospective | 37 | 21/16 | 28 | Proximal humerus tumor | Functional outcome (MSTS), complications and implant survival | Not reported | IV |
| Benedetti [14] | Retrospective | 20 | 17/3 | 14 | Proximal femur tumor | Functional assessment (MSTS) and gait analysis | None | IV |
| Anract [15] (French) | Retrospective | 41 | Not reported | 38 | Proximal femur tumor | Functional outcome (MSTS), complications, implant survival | Not reported | IV |
| Farid [16] | Retrospective | 72 | 45/27 | 69 | Proximal femur tumor | Functional outcome (MSTS), complications, implant survival | None | IV |
| Zehr [17] | Retrospective | 33 | 16/17 | 30 | Proximal femur tumor | Functional outcome (MSTS), complications, implant survival | Not reported | IIB |
| Muller [18] | Retrospective | 42 | 21/21 | 26 | Proximal tibia tumor | Functional outcome (ISOLS), complications, implant survival | None related to the subject of this article. | IV |
| Wunder [19] | Prospective | 75 | Not reported | 75 | Distal femur and proximal tibia tumor | Functional outcome (MSTS), complications, risk of operative revision | Not reported | IV |
| Saidi [20] | Retrospective | 23 | 8/15 | - | Distal femur periprosthetic fracture | Perioperative mobility, complications and return to independence (KSS) | Reported but details not accessible. | IIIB |
| Kassab [21] (French) | Retrospective | 29 | 20/9 | 29 | Proximal humerus tumor | Clinica (MSTS) and radiological results | Not reported | IV |
| Manfrini [22] | Retrospective | 61 | Not reported | 61 | Proximal humerus tumor | Evolution of various limb salvage procedures, radiographic and functional outcome (MSTS) | None | IV |
| Potter [23] | Retrospective | 49 | 29/20 | 43 | Proximal humerus tumor | Functional outcome (MSTS), complications, implant survival | This study was supported by a restricted educational grant from Stryker, and one of the authors is a paid consultant of Stryker | IV |
| Jin Wang [24] (Chinese) | Retrospective | 62 | 29/33 | 62 | Proximal femur tumor | Functional outcome (MSTS) | – | – |
| Hillmann [25] | Retrospective | 110 | 65/45 | 110 | Pelvis tumor | Functional outcome (MSTS) and complications | Not reported | IV |
| Schwameis [26] | Retrospective | 30 | 12/18 | 30 | Pelvis tumor | Functional outcome (MSTS), complications and oncological result | Not reported | IV |
| Nota [27••] | Retrospective | 150 | 74/76 | 150 | Proximal humerus tumor | Functional outcome (MSTS) and complications | None related to the subject of this article | IV |
| Ippolito [28] | Retrospective | 23 | 9/14 | 19 | Periacetabular tumor | Functional outcome (MSTS) and complications | Not reported | IV |
MSTS, musculoskeletal tumour society scoring system; ISOLS, International Society of Limb Salvage; KSS, knee society score